Vimarsana
Biggest News Aggregation in the World

Page 4 - Peginterferon Lambda News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Peginterferon Lambda. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Peginterferon Lambda Today - Breaking & Trending Today

Eiger BioPharmaceuticals Strengthens Leadership Team with New Executive Appointments - Vimarsana News

Eiger BioPharmaceuticals Strengthens Leadership Team with New Executive Appointments

Eiger BioPharmaceuticals Strengthens Leadership Team with New Executive Appointments - read this article along with other careers information, tips and advice on BioSpace

Experimental COVID-19 Treatment Performed Well in Clinical Trial - Vimarsana News

Experimental COVID-19 Treatment Performed Well in Clinical Trial

An experimental treatment greatly reduced the risk of hospitalization and emergency room visits in people who contracted COVID-19, ...

New one-and-done COVID-19 treatment Lambda shows success - Vimarsana News

New one-and-done COVID-19 treatment Lambda shows success

Investigational drug Lambda reduced risk of COVID-19-related death in one of the largest studies of its kind to date.

Eiger BioPharmaceuticals to Host Conference Call to Discuss Phase 3 TOGETHER Study Results of Peginterferon Lambda for COVID-19 on Thursday, March 17, 2022 - Vimarsana News

Eiger BioPharmaceuticals to Host Conference Call to Discuss Phase 3 TOGETHER Study Results of Peginterferon Lambda for COVID-19 on Thursday, March 17, 2022

/PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), a commercial-stage biopharmaceutical company focused on the development of innovative therapies...

Eiger BioPharmaceuticals to Host Conference Call to Discuss Phase 3 TOGETHER Study Results of Peginterferon Lambda for COVID-19 on Thursday, March 17, 2022 - Vimarsana News

Eiger BioPharmaceuticals to Host Conference Call to Discuss Phase 3 TOGETHER Study Results of Peginterferon Lambda for COVID-19 on Thursday, March 17, 2022

/PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), a commercial-stage biopharmaceutical company focused on the development of innovative therapies...